Biotech

All Articles

Roche discards $120M tau possibility, returning legal rights to UCB

.Roche has actually sent back the liberties to UCB's anti-tau antitoxin bepranemab, walking away fro...

Editas builds up in vivo method using $238M Genenvant contract

.Editas Medicines has signed a $238 million biobucks pact to integrate Genevant Scientific research'...

Combo results, Vicodin overlook and celestial security

.Tip has actually reported phase 3 information on its near-approval pain medicine applicant suzetrig...

Angelini pens $360M biobucks treaty for ph. 1 human brain problem drug

.Italy's Angelini Pharma has actually authorized a $360 million biobucks deal fixated a phase 1-stag...

Sage lays off half of R&ampD staff and also agitates C-suite once again

.Sage Therapies' most up-to-date effort to reduce its pipeline and also staff will observe a 3rd of ...

With period 1 record, Mood possesses an eye on early-stage sac cancer

.Along with its own lead prospect in a period 3 trial for an unusual eye cancer, Feeling Biosciences...

Less than a year in, BenevolentAI CEO is out-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our summary of substantial management hirings, firings an...

Roche MAGE-A4 test taken out after key customer review

.Roche has actually produced one more MAGE-A4 system fade away, withdrawing a phase 1 test of a T-ce...

FDA puts partial hold on BioNTech-OncoC4 phase 3 test

.The FDA has actually implemented a predisposed hang on a stage 3 non-small cell lung cancer cells d...

REGiMMUNE, Kiji combine to produce Treg 'very provider,' program IPO

.Taiwan's REGiMMUNE as well as Europe-based Kiji Rehabs are combining to produce a worldwide minded ...